相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Approach to the patient with chronic hepatitis B and decompensated cirrhosis
Mitchell L. Shiffman
LIVER INTERNATIONAL (2020)
Review article: the signalling and functional role of the extracellular matrix in the development of liver fibrosis
Ida Falk Villesen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
The Proposal to Lower P Value Thresholds to .005
John P. A. Ioannidis
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Liver diseases: A major, neglected global public health problem requiring urgent actions and large-scale screening
Patrick Marcellin et al.
LIVER INTERNATIONAL (2018)
Hepatitis B virus infection
Man-Fung Yuen et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Quiescin sulfhydryl oxidase 1 (QSOX1) glycosite mutation perturbs secretion but not Golgi localization
Ben Horowitz et al.
GLYCOBIOLOGY (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics
Jiao Guo et al.
ONCOTARGET (2017)
Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention
Ming Gao et al.
BMC CARDIOVASCULAR DISORDERS (2017)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
Serum thioredoxin reductase is highly increased in mice with hepatocellular carcinoma and its activity is restrained by several mechanisms
Le Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Systematic review with meta-analysis: the proportion of chronic hepatitis B patients with normal alanine transaminase ≤40 IU/L and significant hepatic fibrosis
D. T. Chao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
The Emerging Role of QSOX1 in Cancer
Douglas F. Lake et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Serum thioredoxin reductase levels increase in response to chemically induced acute liver injury
Kang Sun et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase
Benjamin A. Israel et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Proteolytic processing of QSOX1A ensures efficient secretion of a potent disulfide catalyst
Jana Rudolf et al.
BIOCHEMICAL JOURNAL (2013)
Upper limit of normal for alanine aminotransferase: Quo vadis?
L. Pacifico et al.
CLINICA CHIMICA ACTA (2013)
CELL ADHESION Extracellular bonds
Kim Baumann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2013)
A Secreted Disulfide Catalyst Controls Extracellular Matrix Composition and Function
Tal Ilani et al.
SCIENCE (2013)
Efficacy of combined therapy in patients with hepatitis B virus-related decompensated cirrhosis
Guo-Cai Lv et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Pattern of liver enzyme elevations in acute ST-elevation myocardial infarction
David M. Lofthus et al.
CORONARY ARTERY DISEASE (2012)
High Prevalence of Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Patients With Normal ALT in Central Europe
Thomas Goebel et al.
JOURNAL OF MEDICAL VIROLOGY (2011)
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
V. W-S. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Implication of normal liver enzymes in liver disease
Vincenza Calvaruso et al.
JOURNAL OF VIRAL HEPATITIS (2009)
Cellular Sources of Extracellular Matrix in Hepatic Fibrosis
Rebecca G. Wells
CLINICS IN LIVER DISEASE (2008)
The clinical significance of persistently normal ALT in chronic hepatitis B infection
Michelle Lai et al.
JOURNAL OF HEPATOLOGY (2007)
Hepatitis B Virus: Inactive carriers
Sanjeev Kumar Sharma et al.
VIROLOGY JOURNAL (2005)
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values
P Mofrad et al.
HEPATOLOGY (2003)
Healthy ranges for alanine aminotransferase levels
FG De Rosa et al.
ANNALS OF INTERNAL MEDICINE (2003)
Updated definitions of healthy ranges for serum alanine aminotransferase levels
D Prati et al.
ANNALS OF INTERNAL MEDICINE (2002)
Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B
YS Hsu et al.
HEPATOLOGY (2002)